Injectable Hydrogel–Microsphere Construct with Sequential Degradation for Locally Synergistic Chemotherapy DOI
Yuhao Zheng, Yilong Cheng, Jinjin Chen

et al.

ACS Applied Materials & Interfaces, Journal Year: 2017, Volume and Issue: 9(4), P. 3487 - 3496

Published: Jan. 9, 2017

In recent years, in situ chemotherapy mediated by biodegradable polymer platforms has attracted increased attention. Herein, an advanced drug delivery system, combretastatin A-4 (CA4) and docetaxel (DTX)-loaded microsphere embedded injectable thermosensitive polypeptide hydrogel (i.e., hydrogel-microsphere (Gel-MP) construct), was reported for sequential release of drugs with different mechanisms to treat osteosarcoma synergistically. The Gel-MP construct showed biodegradability excellent biocompatibility. CA4 preferentially released from faster degradation disturb the vascular structure tumor reduce exchange nutrients between surrounding tissues, which created interstitial space tissue DTX penetration inhibit cell proliferation. vivo treatment Gel/CA4-MP/DTX efficiently suppressed growth mouse K7 compared other formulations. More importantly, systematical study histopathology immunohistochemistry, can significantly upregulate antiproliferation effect toxicity drugs. Therefore, this locally system a bright prospect clinical application synergistic chemotherapy.

Language: Английский

Highly Stretchable and Biocompatible Strain Sensors Based on Mussel-Inspired Super-Adhesive Self-Healing Hydrogels for Human Motion Monitoring DOI
Xin Jing, Hao‐Yang Mi,

Yu‐Jyun Lin

et al.

ACS Applied Materials & Interfaces, Journal Year: 2018, Volume and Issue: 10(24), P. 20897 - 20909

Published: June 4, 2018

Integrating multifunctionality such as adhesiveness, stretchability, and self-healing ability on a single hydrogel has been challenge is highly desired development for various applications including electronic skin, wound dressings, wearable devices. In this study, novel was synthesized by incorporating polydopamine-coated talc (PDA-talc) nanoflakes into polyacrylamide (PAM) inspired the natural mussel adhesive mechanism. Dopamine molecules were intercalated oxidized, which enhanced dispersion of preserved catechol groups in hydrogel. The resulting dopamine-talc-PAM (DTPAM) showed remarkable with over 1000% extension recovery rate 99%. It also displayed strong adhesiveness to substrates, human adhesion strength surpassed that commercial double-sided tape glue sticks, even dehydrated time. Moreover, DTPAM could rapidly self-heal regain its mechanical properties without needing any external stimuli. excellent biocompatibility improved cell affinity fibroblasts compared PAM When used strain sensor, high sensitivity, gauge factor 0.693 at strain, capable monitoring motions bending finger, knee, or elbow taking deep breath. Therefore, displays favorable attributes suitable use human-friendly biological

Language: Английский

Citations

455

Nanocarrier-based drug combination therapy for glioblastoma DOI Creative Commons
Mengnan Zhao, Demian van Straten, Marike L. D. Broekman

et al.

Theranostics, Journal Year: 2020, Volume and Issue: 10(3), P. 1355 - 1372

Published: Jan. 1, 2020

The current achievements in treating glioblastoma (GBM) patients are not sufficient because many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem cells, drug efflux pumps and DNA damage repair mechanisms.Drug combination therapies have shown increasing benefits against those challenges.With help of nanocarriers, enhancement efficacy safety could be gained using synergistic combinations different therapeutic agents.In this review, we will discuss major issues for GBM treatment, rationales with or without nanocarriers principle enhanced permeability retention effect involved nanomedicine-based targeting promising nanodiagnostics -therapeutics.We also summarize recent progress clinical perspectives nanocarrier-based therapies.The goal article was to provide better understanding key considerations develop new nanomedicine nanotheranostics options fight GBM.

Language: Английский

Citations

293

Frontiers in the treatment of glioblastoma: Past, present and emerging DOI
Taskeen Iqbal Janjua,

Prarthana Rewatkar,

Aria Ahmed-Cox

et al.

Advanced Drug Delivery Reviews, Journal Year: 2021, Volume and Issue: 171, P. 108 - 138

Published: Jan. 22, 2021

Language: Английский

Citations

199

Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment DOI

Lakshmi Pallavi Ganipineni,

Fabienne Danhier, Véronique Préat

et al.

Journal of Controlled Release, Journal Year: 2018, Volume and Issue: 281, P. 42 - 57

Published: May 17, 2018

Language: Английский

Citations

196

Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook DOI
Sepehr Talebian, Javad Foroughi, Samantha J. Wade

et al.

Advanced Materials, Journal Year: 2018, Volume and Issue: 30(31)

Published: May 13, 2018

Abstract In spite of remarkable improvements in cancer treatments and survivorship, still remains as one the major causes death worldwide. Although current standards care provide encouraging results, they cause severe systemic toxicity also fail preventing recurrence disease. order to address these issues, biomaterial‐based implantable drug delivery systems (DDSs) have emerged promising therapeutic platforms, which allow local administration drugs directly tumor site. Owing unique properties biopolymers, been used a variety ways institute biodegradable DDSs that exert precise spatiotemporal control over release drug. Here, most recent advances biopolymer‐based for suppressing growth are reviewed. Novel emerging biopolymers well cutting‐edge polymeric microdevices deployed antitumor discussed. Finally, review new modality within field, is based on biopolymeric DDSs, given.

Language: Английский

Citations

183

Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine DOI
Yan Zou, Yanjie Liu, Zhipeng Yang

et al.

Advanced Materials, Journal Year: 2018, Volume and Issue: 30(51)

Published: Oct. 16, 2018

Glioblastoma multiforme (GBM) is a fatal central nervous system tumor without effective treatment. Chemotherapeutic agents are mainstays in the treatment of glioblastoma. However, effectiveness these seriously hindered by poor blood-brain-barrier (BBB) penetrance and targeting, together with short biological half-life. Improved chemotherapy thus urgently needed for GBM. Multifunctional nanoparticle delivery systems offer much promise overcoming current limitations. Accordingly, multifunctional biomimetic nanomedicine developed functionalizing surface red blood cell membranes (RBCms) angiopep-2 loading pH-sensitive nanoparticles (polymer, doxorubicin (Dox), lexiscan (Lex)) using functionalized membrane to generate novel nanomedicine, Ang-RBCm@NM-(Dox/Lex). The studies toward orthotopic U87MG human glioblastoma tumor-bearing nude mice show that Ang-RBCm@NM-(Dox/Lex) has improved circulation time, superb BBB penetration, superior accumulation retention. Moreover, suppression growth significantly medium survival time also observed after results this nanoplatform can serve as flexible powerful GBM which be readily adapted other (CNS) disorders.

Language: Английский

Citations

181

Advances in Carbon Nanotubes–Hydrogel Hybrids in Nanomedicine for Therapeutics DOI
Arti Vashist, Ajeet Kaushik, Atul Vashist

et al.

Advanced Healthcare Materials, Journal Year: 2018, Volume and Issue: 7(9)

Published: Feb. 1, 2018

In spite of significant advancement in hydrogel technology, low mechanical strength and lack electrical conductivity have limited their next-level biomedical applications for skeletal muscles, cardiac neural cells. Host-guest chemistry based hybrid nanocomposites systems gained attention as they completely overcome these pitfalls generate bioscaffolds with tunable characteristics. recent years, carbon nanotube (CNT)-based hydrogels emerged innovative candidates diverse regenerative medicines, tissue engineering, drug delivery devices, implantable biosensing, biorobotics. This article is an attempt to recapitulate the synthesis characterization provide deep insights toward functioning success devices. The improved comparative performance biocompatibility CNT-hydrogels hybrids developed targeted are addressed here. Recent updates limitations CNT review. will a holistic approach understanding CNT-based nanotheranostics.

Language: Английский

Citations

177

Multifunctional Nanoparticle Loaded Injectable Thermoresponsive Hydrogel as NIR Controlled Release Platform for Local Photothermal Immunotherapy to Prevent Breast Cancer Postoperative Recurrence and Metastases DOI
Yan Jia, Kun Shi, Fan Yang

et al.

Advanced Functional Materials, Journal Year: 2020, Volume and Issue: 30(25)

Published: May 11, 2020

Abstract For breast cancer patients who have undergone breast‐conserving surgery, effective treatments to prevent local recurrences and metastases is very essential. Here, a injectable therapeutic platform based on thermosensitive PLEL hydrogel with near‐infrared (NIR)‐stimulated drug release developed achieve synergistic photothermal immunotherapy for prevention of postoperative relapse. Self‐assembled multifunctional nanoparticles (RIC NPs) are composed three components including indocyanine green, agent; resiquimod (R848), TLR‐7/8 agonist; CPG ODNs, TLR‐9 agonist. RIC NPs physically incorporated into the hydrogel. The encapsulated NPs@PLEL) then locally injected tumor resection cavity therapy ablate residue tissues produce tumor‐associated antigens. At same time, NIR also triggers immune ODNs R848 from thermoresponsive hydrogels PLEL. released components, together antigens, work as an in situ vaccine postsurgical by inducing sustained antitumor effect. Overall, this suggests that delivery system has great potential promising tool management metastases.

Language: Английский

Citations

171

A review on the rheological behavior and formulations of ceramic suspensions for vat photopolymerization DOI
Ítalo Leite de Camargo, Mateus Mota Morais, Carlos Alberto Fortulan

et al.

Ceramics International, Journal Year: 2021, Volume and Issue: 47(9), P. 11906 - 11921

Published: Jan. 8, 2021

Language: Английский

Citations

171

Advances in drug delivery for post-surgical cancer treatment DOI
Lin‐Lin Bu, Junjie Yan, Zejun Wang

et al.

Biomaterials, Journal Year: 2019, Volume and Issue: 219, P. 119182 - 119182

Published: April 28, 2019

Language: Английский

Citations

167